Allosteric Modulation of the RNA Polymerase Catalytic Reaction Is an Essential Component of Transcription Control by Rifamycins

Rifamycins, the clinically important antibiotics, target bacterial RNA polymerase (RNAP). A proposed mechanism in which rifamycins sterically block the extension of nascent RNA beyond three nucleotides does not alone explain why certain RNAP mutations confer resistance to some but not other rifamycins. Here we show that unlike rifampicin and rifapentin, and contradictory to the steric model, rifabutin inhibits formation of the first and second phosphodiester bonds. We report 2.5 A resolution structures of rifabutin and rifapentin complexed with the Thermus thermophilus RNAP holoenzyme. The structures reveal functionally important distinct interactions of antibiotics with the initiation sigma factor. Strikingly, both complexes lack the catalytic Mg2+ ion observed in the apo-holoenzyme, whereas an increase in Mg2+ concentration confers resistance to rifamycins. We propose that a rifamycin-induced signal is transmitted over approximately 19 A to the RNAP active site to slow down catalysis. Based on structural predictions, we designed enzyme substitutions that apparently interrupt this allosteric signal.

[1]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[2]  K. Severinov,et al.  The role of RNA polymerase sigma subunit in promoter-independent initiation of transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. E. Sippel,et al.  Rifampicin resistance of RNA polymerase in the binary complex with DNA. , 1970, European journal of biochemistry.

[4]  F. Monti,et al.  Mode of action of the microbial metabolite GE23077, a novel potent and selective inhibitor of bacterial RNA polymerase. , 2004, European journal of biochemistry.

[5]  P. Gangadharam,et al.  Contribution of rpoB Mutations to Development of Rifamycin Cross-Resistance in Mycobacterium tuberculosis , 1998, Antimicrobial Agents and Chemotherapy.

[6]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[7]  A. Telenti,et al.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.

[8]  C. Cech,et al.  On the mechanism of rifampicin inhibition of RNA synthesis. , 1978, The Journal of biological chemistry.

[9]  G. Węgrzyn,et al.  Differential inhibition of transcription from σ70‐ and σ32‐dependent promoters by rifampicin , 1998 .

[10]  A. Ishihama,et al.  RNA polymerase mutants of Escherichia coli , 1973, Molecular and General Genetics MGG.

[11]  K. Severinov,et al.  The role of RNA polymerase σ subunit in promoter-independent initiation of transcription , 2004 .

[12]  F. Quiocho,et al.  A low energy short hydrogen bond in very high resolution structures of protein receptor-phosphate complexes , 1997, Nature Structural Biology.

[13]  J. Roberts,et al.  Promoter recognition as measured by binding of polymerase to nontemplate strand oligonucleotide. , 1997, Science.

[14]  K. Severinov,et al.  Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Ishihama,et al.  RNA polymerase mutants of Escherichia coli , 1976, Molecular and General Genetics MGG.

[16]  K. Severinov,et al.  Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. , 1993, The Journal of biological chemistry.

[17]  G. Węgrzyn,et al.  Differential inhibition of transcription from sigma70- and sigma32-dependent promoters by rifampicin. , 1998, FEBS Letters.

[18]  W. Zillig,et al.  Rifampicin inhibition of RNA synthesis by destabilisation of DNA-RNA polymerase-oligonucleotide-complexes. , 1981, Nucleic acids research.

[19]  A. Bacchi,et al.  Comprehensive study on structure-activity relationships of rifamycins: discussion of molecular and crystal structure and spectroscopic and thermochemical properties of rifamycin O. , 1998, Journal of medicinal chemistry.

[20]  P. Cramer,et al.  Structural Basis of Transcription: RNA Polymerase II at 2.8 Ångstrom Resolution , 2001, Science.

[21]  R M Esnouf,et al.  Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. , 1999, Acta crystallographica. Section D, Biological crystallography.

[22]  S. Yokoyama,et al.  Structural Basis for Transcription Regulation by Alarmone ppGpp , 2004, Cell.

[23]  W. Wehrli,et al.  The rifamycins--relation of chemical structure and action on RNA polymerase. , 1969, Biochimica et Biophysica Acta.

[24]  T. Wichelhaus,et al.  Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus. , 2001, The Journal of antimicrobial chemotherapy.

[25]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[26]  G. Hartmann,et al.  Influence of temperature on the action of rifampicin on RNA polymerase in presence of DNA. , 1974, European journal of biochemistry.

[27]  T. Jovin,et al.  Binding of Rifampicin to Escherichia coli RNA Polymerase: Thermodynamic and Kinetic Studies , 1976 .

[28]  Arkady Mustaev,et al.  Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase , 2001, Cell.

[29]  S. Yokoyama,et al.  Purification, crystallization and initial crystallographic analysis of RNA polymerase holoenzyme from Thermus thermophilus. , 2002, Acta crystallographica. Section D, Biological crystallography.

[30]  Y. Ovchinnikov,et al.  RNA polymerase rifampicin resistance mutations in Escherichia coli: Sequence changes and dominance , 1983, Molecular and General Genetics MGG.

[31]  A. Hochschild,et al.  Regulation of RNA Polymerase through the Secondary Channel , 2004, Cell.

[32]  M. Chamberlin,et al.  RNA cleavage and chain elongation by Escherichia coli DNA-dependent RNA polymerase in a binary enzyme.RNA complex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Yokoyama,et al.  Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 Å resolution , 2002, Nature.

[34]  R. Young,et al.  RNA polymerase II. , 1991, Annual review of biochemistry.

[35]  K. Murakami,et al.  Co-overexpression of Escherichia coliRNA Polymerase Subunits Allows Isolation and Analysis of Mutant Enzymes Lacking Lineage-specific Sequence Insertions* , 2003, The Journal of Biological Chemistry.

[36]  S. Riva,et al.  Pleiotropic effects of a rifampicin-resistant mutation in E. coli. , 1973, Nature: New biology.

[37]  Steven M. Block,et al.  Transcription Against an Applied Force , 1995, Science.

[38]  K. Severinov,et al.  RifR mutations in the beginning of the Escherichia coli rpoB gene , 1994, Molecular and General Genetics MGG.

[39]  K. Scheit,et al.  The modification of DNA-dependent RNA polymerase from Escherichia coli by an alkylating derivative of rifamycin SV. , 1975, European journal of biochemistry.

[40]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[41]  K. Severinov,et al.  Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase , 2005, The EMBO journal.

[42]  A. Segre,et al.  Structure-activity relationships in the ansamycins. Molecular structure and activity of 3-carbomethoxy rifamycin S. , 1982, Molecular pharmacology.

[43]  C. Gross,et al.  Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. , 1988, Journal of molecular biology.

[44]  H. Floss,et al.  Rifamycin-mode of action, resistance, and biosynthesis. , 2005, Chemical reviews.

[45]  W. Zillig,et al.  Reference mutations for the β subunit of RNA polymerase , 1974, Molecular and General Genetics MGG.

[46]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[47]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[48]  P. V. von Hippel,et al.  Escherichia coli sigma 70 and NusA proteins. I. Binding interactions with core RNA polymerase in solution and within the transcription complex. , 1991, Journal of molecular biology.

[49]  R. Pallanza,et al.  New derivatives of rifamycin SV. , 1965, Antimicrobial agents and chemotherapy.